BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19304665)

  • 1. Heterologous stacking of prion protein peptides reveals structural details of fibrils and facilitates complete inhibition of fibril growth.
    Boshuizen RS; Schulz V; Morbin M; Mazzoleni G; Meloen RH; Langedijk JP
    J Biol Chem; 2009 May; 284(19):12809-20. PubMed ID: 19304665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-rung model of a left-handed beta-helix for prions explains species barrier and strain variation in transmissible spongiform encephalopathies.
    Langedijk JP; Fuentes G; Boshuizen R; Bonvin AM
    J Mol Biol; 2006 Jul; 360(4):907-20. PubMed ID: 16782127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for assembly of prions with left-handed beta-helices into trimers.
    Govaerts C; Wille H; Prusiner SB; Cohen FE
    Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8342-7. PubMed ID: 15155909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion protein misfolding.
    Kupfer L; Hinrichs W; Groschup MH
    Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
    Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
    Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
    Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein self-peptides modulate prion interactions and conversion.
    Rigter A; Priem J; Timmers-Parohi D; Langeveld JP; van Zijderveld FG; Bossers A
    BMC Biochem; 2009 Nov; 10():29. PubMed ID: 19943977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational polymorphism of the amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.
    De Gioia L; Selvaggini C; Ghibaudi E; Diomede L; Bugiani O; Forloni G; Tagliavini F; Salmona M
    J Biol Chem; 1994 Mar; 269(11):7859-62. PubMed ID: 7907586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetracycline affects abnormal properties of synthetic PrP peptides and PrP(Sc) in vitro.
    Tagliavini F; Forloni G; Colombo L; Rossi G; Girola L; Canciani B; Angeretti N; Giampaolo L; Peressini E; Awan T; De Gioia L; Ragg E; Bugiani O; Salmona M
    J Mol Biol; 2000 Jul; 300(5):1309-22. PubMed ID: 10903871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein.
    Wang LQ; Zhao K; Yuan HY; Wang Q; Guan Z; Tao J; Li XN; Sun Y; Yi CW; Chen J; Li D; Zhang D; Yin P; Liu C; Liang Y
    Nat Struct Mol Biol; 2020 Jun; 27(6):598-602. PubMed ID: 32514176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The key-role of tyrosine 155 in the mechanism of prion transconformation as highlighted by a study of sheep mutant peptides.
    Bertho G; Bouvier G; Hoa GH; Girault JP
    Peptides; 2008 Jul; 29(7):1073-84. PubMed ID: 18455265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
    Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
    J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
    Singh J; Udgaonkar JB
    J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How does domain replacement affect fibril formation of the rabbit/human prion proteins.
    Yan X; Huang JJ; Zhou Z; Chen J; Liang Y
    PLoS One; 2014; 9(11):e113238. PubMed ID: 25401497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization.
    Corsaro A; Anselmi C; Polano M; Aceto A; Florio T; De Nobili M
    J Biol Regul Homeost Agents; 2010; 24(1):27-39. PubMed ID: 20385069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of amyloid formation by Ab peptide: review of own works].
    Selivanova OM; Rogachevsky VV; Syrin AK; Galzitskaya OV
    Biomed Khim; 2018 Jan; 64(1):94-109. PubMed ID: 29460839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.